Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wellgistics Health (WGRX) Gains from Investment Securities (2025)

Wellgistics Health's Gains from Investment Securities history spans 1 years, with the latest figure at -$2.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities changed N/A year-over-year to -$2.6 million, compared with a TTM value of $19.8 million through Jun 2025, changed N/A, and an annual FY2025 reading of $20.6 million, changed N/A over the prior year.
  • Gains from Investment Securities for Q4 2025 was -$2.6 million at Wellgistics Health, down from $19.8 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $27.2 million in Q1 2025, with the low at -$2.6 million in Q4 2025.